Association of antibody responses to microbial antigens and complications of small bowel Crohn’s disease-Reference-Cited by-全球学者库

Association of antibody responses to microbial antigens and complications of small bowel Crohn’s disease

Published:2004-02 Issue:2 Volume:126 Page:414-424
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Mow William S.,Vasiliauskas Eric A.,Lin Ying-Chao,Fleshner Phillip R.,Papadakis Konstantinos A.,Taylor Kent D.,Landers Carol J.,Abreu-Martin Maria T.,Rotter Jerome I.,Yang Huiying,Targan Stephan R.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference43 articles.

1. The immunology of mucosal models of inflammation;Strober;Ann Rev Immunol,2002

2. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease;Blumberg;Curr Opin Immunol,1999

3. Mucosal immunity and inflammation. II. The yin and yang of T cells in intestinal inflammation: pathogenic and protective roles in a mouse colitis model;De Winter;Am J Physiol,1999

4. Colitis induced by enteric bacterial antigen-specific CD4+ T cells requires CD40-CD40 ligand interactions for a sustained increase in mucosal IL-12;Cong;J Immunol,2000

5. CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice;Cong;J Exp Med,1998

Cited by 438 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From ASCA breakthrough in Crohn's disease and Candida albicans research to thirty years of investigations about their meaning in human health;Autoimmunity Reviews;2024-02

2. Intestinal Inflammation and Regeneration–Interdigitating Processes Controlled by Dietary Lipids in Inflammatory Bowel Disease;International Journal of Molecular Sciences;2024-01-21

3. Clinical validation of serum immunosignatures in early diagnosis of Crohn's disease;iLABMED;2023-12

4. Precision medicine in inflammatory bowel disease;Precision Clinical Medicine;2023-10-25

5. A blood-based transcriptomic signature stratifies severe Crohn’s disease and defines potentially targetable therapeutic pathways;Frontiers in Gastroenterology;2023-10-18